BIO Asia-International | March 9, 2021 | Business & BIO Industry, Business Development, Pre-Clinical Research, Cancer/Oncology, Immunotherapy, RNA Interference (RNAi), Therapeutic Areas, Oncology, Committee on Foreign Investment in the United States (CFIUS), International Issues, Asia Issues, Network & Partnering, Networking, BIO One-on-One Partnering